<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03222102</url>
  </required_header>
  <id_info>
    <org_study_id>Ventral hernia prevention</org_study_id>
    <nct_id>NCT03222102</nct_id>
  </id_info>
  <brief_title>Ventral Hernia Prevention After Liver Transplantation</brief_title>
  <official_title>Ventral Hernia Prevention After Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate if the risk of developing ventral hernia after liver&#xD;
      transplantation can be reduced through the prophylactic implantation of a synthetic, fully&#xD;
      resorbable mesh &quot;Phasix&quot; in the course of liver transplantation.&#xD;
&#xD;
      Patients will be randomized in a 1:1 ratio to receive either Phasix mesh or standard surgery&#xD;
      without the use of Phasix.&#xD;
&#xD;
      Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months&#xD;
      after liver transplantation. Furthermore, presence of infections, seroma, pain and other&#xD;
      problems in the wound area will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ventral hernia is a frequently occurring complication following liver transplantation, with a&#xD;
      reported risk in the literature ranging from 5% to 25%.&#xD;
&#xD;
      This study aims to evaluate if the risk of developing ventral hernia after liver&#xD;
      transplantation can be reduced through the prophylactic implantation of a synthetic mesh&#xD;
      &quot;Phasix&quot; in the course of liver transplantation.&#xD;
&#xD;
      PHASIX™ Mesh is a fully resorbable mesh implant prepared from poly-4-hydroxybutyrate (P4HB).&#xD;
      Absorption of the mesh material occurs within 12 to 18 months.&#xD;
&#xD;
      Patients will be randomized in a 1:1 ratio to receive either Phasix mesh in the course of&#xD;
      liver transplantation or standard surgery without the use of Phasix.&#xD;
&#xD;
      Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months&#xD;
      after liver transplantation. Furthermore, presence of infections, seroma, pain and other&#xD;
      problems in the wound area will be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of ventral hernia</measure>
    <time_frame>12 months after liver transplantation</time_frame>
    <description>Evaluated by ultra-sound imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infections</measure>
    <time_frame>12 months after liver transplantation</time_frame>
    <description>Number of infections in the wound area, assessed by clinical evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound healing disorders</measure>
    <time_frame>12 months after liver transplantation</time_frame>
    <description>Presence of wound healing disorders in the wound area, assessed by clinical evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seroma</measure>
    <time_frame>12 months after liver transplantation</time_frame>
    <description>Presence of seroma in the wound area, assessed by clinical evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematoma</measure>
    <time_frame>12 months after liver transplantation</time_frame>
    <description>Number of hematoma in the wound area, assessed by clinical evaluation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Ventral Hernia</condition>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Phasix mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phasix mesh will be affixed to the exposed fascia after closure of the Abdomen in the course of liver transplantation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard surgery</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Surgery will be performed according to routine, without the use of Phasix mesh.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Phasix mesh</intervention_name>
    <description>After the closure of the Abdomen, Phasix mesh will be placed and affixed on the exposed fascia.</description>
    <arm_group_label>Phasix mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  First transplantation&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Combined transplantation&#xD;
&#xD;
          -  Revisions after liver transplantation&#xD;
&#xD;
          -  Patients who already received laparotomy or transverse upper laparotomy (longer than&#xD;
             15 cm)&#xD;
&#xD;
          -  Preexisting abdominal wall hernia except umbilical hernia after liver transplantation&#xD;
&#xD;
          -  Pregnant/lactating women&#xD;
&#xD;
          -  Known allergies to tetracycline hydrochloride and kanamycin sulfate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Daniela Kniepeiss, MD</last_name>
    <phone>0043 316 385 13893</phone>
    <email>daniela.kniepeiss@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Auer, MD, Professor</last_name>
    <email>thomas.auer@medunigraz.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Graz; Klin. Abteilung für Transplantationschirurgie</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Kniepeiss, MD</last_name>
      <phone>0043 316 385 13893</phone>
      <email>daniela.kniepeiss@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Auer, Prof.</last_name>
      <phone>0043 316-385-81183</phone>
      <email>thomas.auer@medunigraz.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2017</study_first_posted>
  <last_update_submitted>July 6, 2020</last_update_submitted>
  <last_update_submitted_qc>July 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

